ES2101164T3 - Composiciones farmaceuticas orales para el suministro especifico al colon. - Google Patents

Composiciones farmaceuticas orales para el suministro especifico al colon.

Info

Publication number
ES2101164T3
ES2101164T3 ES93108658T ES93108658T ES2101164T3 ES 2101164 T3 ES2101164 T3 ES 2101164T3 ES 93108658 T ES93108658 T ES 93108658T ES 93108658 T ES93108658 T ES 93108658T ES 2101164 T3 ES2101164 T3 ES 2101164T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
colon
oral pharmaceutical
nucleus
specific supply
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93108658T
Other languages
English (en)
Other versions
ES2101164T5 (es
Inventor
Stefano Poli
Cesare Busetti
Luigi Moro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poli Industria Chimica SpA
Original Assignee
Poli Industria Chimica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11363431&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2101164(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Industria Chimica SpA filed Critical Poli Industria Chimica SpA
Application granted granted Critical
Publication of ES2101164T3 publication Critical patent/ES2101164T3/es
Publication of ES2101164T5 publication Critical patent/ES2101164T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICIONES FARMACEUTICAS, DE ADMINISTRACION POR VIA ORAL, CONSTITUIDAS POR: A) UN NUCLEO QUE CONTIENE EL PRINCIPIO ACTIVO DE UNA MEZCLA DE PRINCIPIOS ACTIVOS, OPCIONALMENTE COMBINADOS CON EXCIPIENTES; B) UNA CAPA INTERMEDIA DE REVESTIMIENTO DEL CITADO NUCLEO, QUE PUEDE RETRASAR EL PRINCIPIO ACTIVO CONTENIDO EN EL NUCLEO DURANTE EL TIEMPO PROGRAMADO, INDEPENDIENTEMENTE DEL PH; C) OTRA CAPA EXTERIOR, CUYA DISOLUCION ACTIVA EL PROCESO DE DILATACION/DISOLUCION/EROSION DE LA CAPA INTERMEDIA DE REVESTIMIENTO DEL PUNTO B).
ES93108658T 1992-06-01 1993-05-28 Composiciones farmaceuticas orales para el suministro especifico al colon. Expired - Lifetime ES2101164T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921347A IT1260505B (it) 1992-06-01 1992-06-01 Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon

Publications (2)

Publication Number Publication Date
ES2101164T3 true ES2101164T3 (es) 1997-07-01
ES2101164T5 ES2101164T5 (es) 2001-02-01

Family

ID=11363431

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93108658T Expired - Lifetime ES2101164T5 (es) 1992-06-01 1993-05-28 Composiciones farmaceuticas orales para el suministro especifico al colon.

Country Status (8)

Country Link
EP (1) EP0572942B2 (es)
AT (1) ATE151285T1 (es)
DE (1) DE69309540T3 (es)
DK (1) DK0572942T4 (es)
ES (1) ES2101164T5 (es)
GR (2) GR3023605T3 (es)
HU (1) HUT75158A (es)
IT (1) IT1260505B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
US5482718A (en) * 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
NL1009107C2 (nl) 1997-11-12 1999-06-15 Banner Pharmacaps Inc Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel.
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
UA74141C2 (uk) 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
IL143604A0 (en) 1998-12-30 2002-04-21 Dexcel Ltd Dispersable concentrate for the delivery of cyclosporin
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
KR20040047747A (ko) 2001-03-13 2004-06-05 펜웨스트 파머슈티칼즈 컴파니 변시치료 제형
FR2830446B1 (fr) * 2001-10-09 2004-02-06 Univ Pasteur Composition pharmaceutique destinee a liberer une substance active au niveau du colon
BR0315731A (pt) * 2002-10-30 2005-09-06 Pharmacia Corp Comprimidos orais de liberação prolongada e métodos para fabricar e usar os mesmos
CU23334A1 (es) * 2003-03-20 2008-12-24 Inst Finlay Vacuna de vibrio cholerae inactivada en tabletas
EA200600598A1 (ru) 2003-09-19 2006-08-25 Пенвест Фармасьютикалз Ко. Лекарственные формы замедленного высвобождения
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
ITMI20041295A1 (it) * 2004-06-25 2004-09-25 Cosmo Spa Composizioni farmaceutiche antimicrobiche orali
EP1754471A1 (de) * 2005-08-18 2007-02-21 ORAMON-Arzneimittel GmbH & Co. KG Verwendung einer quellbaren Zwischenschicht zur Steuerung des Freisetzungsprofils einer festen Arzneimittelformulierung zur peroralen Anwendung und diese enthaltende Arzneimittelformulierung
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
US20110117142A1 (en) * 2008-07-02 2011-05-19 Basf Se Method for coating tablets
IT1393244B1 (it) 2008-07-18 2012-04-12 Universita' Degli Studi Di Milano Sistema per il rilascio al colon di farmaci suscettibili di degradazione enzimatica e/o scarsamente assorbiti nel tratto gastrointestinale
DK2387580T3 (da) 2009-01-14 2014-10-13 Novacta Biosystems Ltd Deoxyactagardinderivater
EA020733B1 (ru) 2009-02-04 2015-01-30 Новакта Биосистемс Лимитед Производные актагардина
WO2015161139A1 (en) 2014-04-16 2015-10-22 Rapamycin Holdings, Llc Oral rapamycin preparation and use for stomatitis
US10391059B2 (en) 2009-11-11 2019-08-27 Rapamycin Holdings, Inc. Oral rapamycin nanoparticle preparations and use
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
US20130115280A1 (en) 2010-07-29 2013-05-09 Cosmo Technologies Ltd Pharmaceutical and/or dietary compositions based on sort chain fatty acids
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
US20140227293A1 (en) 2011-06-30 2014-08-14 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
CA2901284A1 (en) 2013-04-05 2014-10-09 Polichem Sa Use of pidotimod to treat irritable bowel syndrome
CN105943505A (zh) * 2016-05-26 2016-09-21 杭州百诚医药科技股份有限公司 一种匹多莫德药物组合物及其制备方法
US20210046011A1 (en) 2019-08-12 2021-02-18 Massachusetts Institute Of Technology Articles and methods for administration of therapeutic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
US5032406A (en) † 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
PH27186A (en) † 1989-09-07 1993-04-16 Ciba Geigy Ag Double-coated granules of disodium pamidronate
DK469989D0 (da) † 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon

Also Published As

Publication number Publication date
DE69309540D1 (de) 1997-05-15
HUT75158A (en) 1997-04-28
DE69309540T3 (de) 2001-03-15
ITMI921347A1 (it) 1993-12-01
ES2101164T5 (es) 2001-02-01
DK0572942T4 (da) 2001-01-22
EP0572942A3 (en) 1994-08-24
EP0572942A2 (en) 1993-12-08
EP0572942B2 (en) 2000-11-29
HU9301577D0 (en) 1993-09-28
ITMI921347A0 (it) 1992-06-01
DE69309540T2 (de) 1997-09-04
EP0572942B1 (en) 1997-04-09
GR3035415T3 (en) 2001-05-31
IT1260505B (it) 1996-04-09
GR3023605T3 (en) 1997-08-29
ATE151285T1 (de) 1997-04-15
DK0572942T3 (da) 1997-10-20

Similar Documents

Publication Publication Date Title
ES2101164T5 (es) Composiciones farmaceuticas orales para el suministro especifico al colon.
PE20020307A1 (es) Forma de dosificacion de farmaco activada por hidrogel
AR028504A2 (es) Combinacion, metodo para mejorar la apariencia corporal de un mamifero, composicion farmaceutica, uso de dicha combinacion para la preparacion de un medicamento para la prevencion, demora de progreso, o tratamiento de desordenes metabolicos, y paquete comercial
AR061169A1 (es) Formulaciones farmaceuticas de fenilferina y composiciones para su absorcion en el colon
IT1245889B (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
ES2096080T3 (es) Formas de presentacion de un medicamento conteniendo pantoprazol y administrado por via oral.
AR006678A1 (es) Derivados de macrolidas triciclicas, una composicion farmaceutica que los contiene, uso de los mismos para preparar medicamentos y procedimientopara su preparacion
AR098745A2 (es) Composición, kit y uso de compuestos quimioterapéuticos
ES2149979T3 (es) Composicion estabilizada para la administracion oral de peptidos.
ES2546847T3 (es) Formulaciones de un inhibidor de la Src/Abl
PT102457A (pt) Composicao farmaceutica contendo um inibidor selectivo de pde5
UY26371A1 (es) Imidazo-3-il-aminas biciclicas, procedimiento para su preparacion y medicamentos que las contienen
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
ES479423A1 (es) Procedimiento para la preparacion de 2-2-tenoiltio-propio- nil-glicina.
DE60030283D1 (de) Zusammensetzungen zur erhöhung der bioverfügbarkeit von oral verabreichten pharmazeutischen verbindungen
PA8523101A1 (es) Composicion de eletriptan en forma de particulas
AR006892A1 (es) Uso de formas del acido hialuronico (ha) para el tratamiento del cancer
AR005102A1 (es) Compuestos derivados de octahidro-pirrolo [1,2-a]-pirazina 2,7-sustituidos, composiciones farmaceuticas y uso de dichos compuestos para la fabricacion deun medicamento.
CO5550418A2 (es) Formulaciones antihistaminicas para formas de dosificacion de capsula blanda
ES2093246T3 (es) Compuestos de benzazepina terapeuticos.
UY26211A1 (es) Polimorfos de un diclorhidrato cristalino de azobiciclo (2.2.2)oct-3-ilamina y sus composiciones farmaceuticas
AR018032A1 (es) Derivados del indol-aril sustituidos, un procedimiento para su preparacion, composicion farmaceutica que los comprende y el uso de dichos compuestos parala fabricacion de un medicamento
RU2003105601A (ru) Лекарственный препарат, предназначенный для лечения сексуальных расстройств
BRPI0413374A (pt) composições para liberação de base fraca por um perìodo estendido de tempo
AR012602A1 (es) Derivados de amidina, formulacion farmaceutica, uso de dichos derivados para la fabricacion de medicamentos y proceso para la preparacion de dichosderivados

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 572942

Country of ref document: ES